Search Results
Jun 15, 2026, 09:00 ET QuEra Announces 2028 Fault-Tolerant Quantum Computer and Expanded Multi-Year Strategic Collaboration with AWS
a single environment to develop and run quantum applications alongside their existing classical infrastructure, with native integration to HPC and AI/ML resources, for hybrid quantum-classical workflows. The collaboration deepens a relationship that began in 2022, when Aquila became the first neutral-atom
More news about: QuEra Computing
Jun 15, 2026, 08:47 ET Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
As an expansion of the TruCan Ultra line, this new 1/2 mL formulation provides the same broad protection as the category-exclusive 1 mL version but in half the volume. This combination formulation allows veterinarians to provide essential protection
More news about: Elanco Animal Health
Jun 15, 2026, 08:35 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026
1-800-FDA-1088.Dosage Forms and Strengths: CRENESSITY is available in 50 mg and 100 mg capsules, and as an oral solution of 50 mg/mL.Please see full
More news about: Neurocrine Biosciences, Inc.
Jun 15, 2026, 08:30 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026
www.fda.gov/medwatch or call 1-800-FDA-1088.Dosage Forms and Strengths: CRENESSITY is available in 50 mg and 100 mg capsules, and as an oral solution of 50 mg/mL.Please see full
More news about: Neurocrine Biosciences, Inc.
Jun 15, 2026, 08:00 ET Intellias achieves AWS AI Services Competency
implementations:For a property intelligence company, Intellias modernized an aerial imagery analysis platform by migrating a legacy batch-based ML pipeline to an AWS serverless architecture. The result was a tenfold reduction in the total cost of ownership and faster property risk assessments.For
More news about: Intellias
Jun 15, 2026, 06:00 ET EcoVadis Joins European Commission's AI Act Advisory Forum to Shape Future of Responsible AI
and responsible AI, ultimately helping to shape a regulatory landscape that fosters trust and innovation across Europe," says Sophia Katrenko, VP of AI/ML at EcoVadis.Established under Article 67 of the EU AI Act, the Advisory Forum acts as a vital bridge between EU regulators - specifically the
More news about: EcoVadis
Jun 12, 2026, 20:30 ET Simcere Pharmaceutical sluit samenwerkingsovereenkomst voor onderzoek met Stanford Medicine voor de ontwikkeling van innovatieve behandelingen voor patiënten met idiopathische pulmonale fibrose
-onderzoek-met-stanford-medicine-voor-de-ontwikkeling-van-innovatieve-behandelingen-voor-patienten-met-idiopathische-pulmonale-fibrose-302799527.html
More news about: Simcere Pharmaceutical Group Limited
Jun 12, 2026, 14:10 ET Hippocratic AI Launches LLM Model Training Residency for Top Engineers Interested in Career-Shaping Work
publications. Residents fine-tune models, run experiments on Hippocratic AI's NVIDIA H200 and B300 GPU cluster, ship a real capstone, and work 1:1 with senior ML engineers from the team behind Polaris - the company's patented constellation LLM. The residency is extra-curricular — roughly 10 hours per week alongside
More news about: Hippocratic AI
Jun 12, 2026, 09:00 ET Braeburn to Present Research at CPDD 2026 Annual Meeting, Including Data on Withdrawal Suppression and Real-World Treatment Retention in Patients With Opioid Use Disorder
program and comply with the REMS requirements.BRIXADI (buprenorphine) extended-release injection (weekly, 50 mg/mL buprenorphine) and BRIXADI (monthly, 356 mg/mL buprenorphine) are different formulations. Doses of BRIXADI (weekly) cannot be combined to yield an equivalent monthly dose.CONTRAINDICATIONSBRIXADI
More news about: Braeburn
Jun 12, 2026, 03:00 ET AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
renal function (CrCl <80 mL/min) may require more intensive prophylaxis and monitoring to reduce the risk of TLS at initiation and during the dose-titration phase. Venetoclax should be administered to patients with severe renal impairment (CrCl ≥15 ml/min and <30 ml/min) or end-stage renal disease
More news about: AbbVie
Jun 12, 2026, 03:00 ET AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
renal function (CrCl <80 mL/min) may require more intensive prophylaxis and monitoring to reduce the risk of TLS at initiation and during the dose-titration phase. Venetoclax should be administered to patients with severe renal impairment (CrCl ≥15 ml/min and <30 ml/min) or end-stage renal disease
More news about: AbbVie
Jun 11, 2026, 17:28 ET Greenland Energy Company Announces Addition of Carol Craig to Board of Directors
solutions, including satellite manufacturing and technology integration, AI-driven space-based data solutions, mission planning and management operations, AI/ML products and services, and space and defense hardware manufacturing. With its mission of Space Access Reimagined®, Sidus Space is committed to rapid
More news about: Greenland Energy Company
Jun 11, 2026, 15:56 ET CINC Systems and HOA Invest Partner to Automate Off-Book Reserve Visibility for Community Association Management
outside the management company's integrated banking partners—typically a brokerage or custodial account at a broker-dealer (for example, Merrill Lynch "ML", Morgan Stanley "MS", LPL Financial, or UBS, etc.)—so balances, transactions and statements are not automatically visible inside the management company's
More news about: CINC Systems
Jun 11, 2026, 12:57 ET Commerce Department Preliminary Antidumping Duties of 130.76% on Chinese Van-Type Trailer Imports an "Important Victory for American Manufacturing," says American Trailer Manufacturers Coalition
0-76-on-chinese-van-type-trailer-imports-an-important-victory-for-american-manufacturing-says-american-trailer-manufacturers-coalition-302798367.htmlSOURCE American Trailer Manufacturers Coalition
More news about: American Trailer Manufacturers Coalition
Jun 11, 2026, 11:10 ET Award-Winning Chinola Fresh Fruit Liqueurs Expands Portfolio with New Guava Expression
variety of tropical growing regions, while keeping its rum and production centered in the Dominican Republic.Chinola Guava Liqueur ($32.99, 750ml) is available for pre-order via
More news about: Chinola Fresh Fruit Liqueurs
Jun 11, 2026, 10:15 ET Warehouse Robotics Software Market worth $4.47 billion by 2031 - Exclusive Report by MarketsandMarkets™
environments.By Software type, fleet management & orchestration holds largest share. AI-powered picking optimization is fastest-growing using ML for dynamic task assignment and path optimization.By Deployment, Cloud/SaaS dominates driven by multi-site visibility and reduced IT overhead.
More news about: MarketsandMarkets
Jun 11, 2026, 09:22 ET Laminar Named a 2026 World Economic Forum Technology Pioneer
chemicals, and energy. Laminar fixes the waste from these processes with real-time sensor data of the actual process state and uses its foundational ML models to adapt every cycle based on what the process is doing. The result is self-driving processes that self-correct in real-time."In every
More news about: Laminar
Jun 11, 2026, 09:07 ET Laminar Named a 2026 World Economic Forum Technology Pioneer
chemicals, and energy. Laminar fixes the waste from these processes with real-time sensor data of the actual process state and uses its foundational ML models to adapt every cycle based on what the process is doing. The result is self-driving processes that self-correct in real-time."In every
More news about: Laminar
Jun 11, 2026, 09:00 ET Abbott recebe aprovação para dois novos biossimilares no Brasil, ampliando o acesso ao tratamento da osteoporose e de complicações ósseas relacionadas ao câncer
https://www.mdpi.com/1999-4923/18/3/291. RESYNIV® 60 MG/ML (DENOSUMABE). MS: 1.0553.0403. USO ADULTO. VIA SUBCUTÂNEA. INDICAÇÕES: Resyniv é indicado para mulheres na pós-menopausa com Osteoporose; perda óssea
More news about: Abbott
Jun 11, 2026, 08:00 ET Shutterstock Evolves Its Content Library into a Human-Led, AI-Powered Creative Platform
includes high-quality labeled and continuously updated multimodal content with clear data provenance to support AI compliance. Shutterstock leverages ML-assisted evaluation tools to provide model training, fine-tuning, alignment, evaluation, and retraining. Through human-in-the-loop workflows, expert
More news about: Shutterstock, Inc.
Jun 11, 2026, 07:08 ET Sight Machine Launches Agentic Manufacturing Platform That Understands Your Plant - and Improves It, Every Run
the enterprise can access it. Push findings into Microsoft Teams, Microsoft Fabric, and Microsoft Excel. Run Omniverse simulations. Connect Databricks ML models. Intelligence flows both ways, and the compound effects reach across the firm.Security is structural throughout: each deployment is single-tenant
More news about: Sight Machine Inc.
Jun 11, 2026, 07:00 ET Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
(NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target discovery powered by AI/ML, today announced that it will present a trial-in-progress poster on the MAIA-ovarian Phase 1 study of COM701, a potential first-in-class anti-PVRIG
More news about: Compugen Ltd.
Jun 11, 2026, 02:03 ET IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
and discuss any questions you have with your doctor.Dosage Form and Strengths: IMAAVY is supplied as a 300 mg/1.62 mL and a 1,200 mg/6.5 mL (185 mg/mL) single-dose vial per carton for intravenous injection.ABOUT JOHNSON & JOHNSONAt Johnson & Johnson, we
More news about: Johnson & Johnson
Jun 10, 2026, 10:00 ET Marina Abramović Interprets Ornellaia 2023 "La Vitalità"
berries began to vibrate. A vital force, petals of energy blooming from the mind," explains Marina AbramovićFor the label featured on the 750ml bottle, Marina-Medusa is portrayed as a simple drawing, while her face, almost entirely surrounded by bunches of grapes, is depicted on the labels
More news about: Ornellaia
Jun 10, 2026, 09:01 ET HOPPR to Showcase Pioneering Catalyst Research Projects at SIIM26, Open Applications for New Cohort
Assistant Professor at the University of Illinois Cancer Center."HOPPR bridges the gap between clinical and technical expertise required to develop ML methods for healthcare applications," said Udunna Anazodo, Ph.D., Scientific Director of MAI Lab Lagos and Assistant Professor at McGill University.Attendees
More news about: HOPPR